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Retinoic acid derivatives have been used successfully for the treatment of various dermatoses, such as psoriasis;
however, topical application of these compounds often elicits skin irritation. We hypothesized that this irritation
was as a result of the local production of interleukin-8 (IL-8). To test this hypothesis, we investigated whether all-
trans-retinoic acid (ATRA) induced IL-8 production in normal human keratinocytes. Stimulation with 107 M ATRA
enhanced IL-8 mRNA expression and induced IL-8 production. We also studied the intracellular signaling mech-
anisms of ATRA-induced IL-8 production in keratinocytes. ATRA increased the expression of RelA (p65), RelB,
nuclear factor (NF)-jB2 (p52), and NF-jB1 (p50), and elevated the DNA-binding activity of p65 and phosphorylation
of inhibitor jB (IjB) a. Introduction of a dominant-negative mutant of IjBa completely abolished ATRA-induced IL-8
production, which indicates that this process is NF-jB-dependent. We also studied the role of the p38 mitogen-
activated protein kinase (MAPK) pathway in this phenomenon. ATRA phosphorylated the p38 MAPK, and SB202180
inhibited ATRA-induced IL-8 production, which indicates that the p38 MAPK is also involved in ATRA-induced IL-8
production. In summary, ATRA induces IL-8 production in both NF-jB- and p38 MAPK-dependent manners in
normal human keratinocytes.
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Retinoids include natural and synthetic compounds with
specific biological activity similar to that of Vitamin A (retinol)
(Orfanos et al, 1997). Retinol and its derivative acid are
widely used to treat acne, psoriasis, and photo-aged skin.
Despite their many beneficial effects, however, topical ap-
plication of retinoids often causes local irritation that is
manifested as redness, scaling, and dryness (Kang et al,
1995; Ale et al, 1997). The mechanism of retinoic acid-in-
duced inflammation is poorly understood. The important
role of interleukin-8 (IL-8) in the progress of irritation has
been demonstrated (Schroder, 1995). A recent report
showed that treatment with 2% retinol upregulated the lev-
el of IL-8 mRNA in the ear epidermis of BALB/c mice (Kim
et al, 2003), and that anti-irritants significantly inhibited re-
tinoid-induced IL-8 in cultured keratinocytes (Kim et al,
2003), indicating that IL-8 plays a central role in retinoid-
induced skin irritation. Although human keratinocytes pro-
duce IL-8 in response to retinoids (Kim et al, 2003), the
molecular mechanism involved is unclear.
IL-8 is a member of the C–X–C subfamily of chemokines
(CXCL8; Zlotnik and Yoshie, 2000). As a key factor in the
pathogenesis of inflammatory diseases, IL-8 has diverse
biological properties, including chemotaxis of neutrophils
and T lymphocytes (Baggiolini et al, 1989), regulation of cell
adhesion (Djeu et al, 1990), activation of neutrophils (Muk-
aida et al, 1992), and modulation of histamine release (Kuna
et al, 1991). Therefore, it seems worthwhile to investigate
the potential role of IL-8 in retinoic acid-induced skin in-
flammation. Various cell types, such as endothelial cells,
epithelial cells, synovial cells, T cells, fibroblasts, keratin-
ocytes, chondrocytes, and some tumor cells, have been
shown to produce IL-8 (Hoffmann et al, 2002). The classical
inducers of IL-8 are inflammatory stimuli, such as IL-1,
tumor necrosis factor (TNF)-a, bacterial lipopolysaccharides
(LPS), 12-O-tetradecanoylphorbol-13-acetate, viruses, and
double-stranded RNA (Hoffmann et al, 2002). IL-8 produc-
tion is regulated at both the transcriptional and post-tran-
scriptional levels. The 30-end of the IL-8 transcript contains
an AU-rich cis-element (ARE), which is responsible for the
destabilization of a variety of cytokine mRNA (Shaw and
Kamen, 1986). The sequence that spans nucleotides (nt) 1
to 133 within the 50-flanking region of the IL-8 gene is
essential and sufficient for transcriptional regulation of the
gene. The core IL-8 promoter contains a nuclear factor-kB
(NF-kB) element that is required for activation in all of the
cell types studied, and it also contains activating protein
(AP)-1- and CCAAT/enhancer-binding protein (C/EBP)-bind-
ing sites. The latter two sites are dispensable for transcrip-
tional activation in some cell types, but contribute to
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activation in other cell types. Thus, unlike the NF-kB site,
the AP-1 and C/EBP sites are not essential for IL-8 gene
induction, but are required for maximal gene expression
(Hoffmann et al, 2002).
Cytokines and chemokines play important roles in the
pathogenesis of various dermatoses. Based of the results of
biochemical analyses and in vitro studies, it is clear that IL-8
contributes significantly to the pathological changes seen in
psoriasis (Sticherling et al, 1991a, b, 1999; Takematsu and
Tagami, 1993). The involvement of IL-8 in other dermatoses,
such as bullous pemphigoid (Baroni et al, 2002), erythema
migrans (Grygorczuk et al, 2002), atopic dermatitis, and al-
lergic contact dermatitis (Albanesi et al, 2001), has also
been demonstrated. The erythematous reaction in retinoid-
induced skin irritation is clinically similar to a mild irritant
dermatitis (Fisher et al, 1991; Ale et al, 1997; Grygorczuk
et al, 2002). In particular, activated keratinocytes are an im-
portant source of chemotactic factors that direct the re-
cruitment of specific leukocyte populations and regulate the
quality, magnitude, and duration of the inflammatory re-
sponse. Normal cultured human keratinocytes have been
shown to produce IL-8 after appropriate stimulation (Larsen
et al, 1989; Boorsma et al, 1994; Stoof et al, 2001).
Retinoic acid modulates immunological and inflammato-
ry responses, most probably by regulating cytokine pro-
duction, although it also affects epidermal cell growth and
differentiation (Zitnik et al, 1994; Sawatsri et al, 2000). As
retinoic acid upregulates IL-8 expression in fibroblasts
(Zhang et al, 1992), neuroblastoma cells (Yang et al, 1993),
and a human ovarian carcinoma cell line (Harant et al, 1995),
we hypothesized that retinoic acid might also induce IL-8
production in human keratinocytes. To test this hypothesis,
we investigated whether all-trans-retinoic acid (ATRA) was
able to induce IL-8 production in cultured normal human
keratinocytes, and we assessed the involvement of the NF-
kB and p38 mitogen-activated protein kinase (MAPK) path-
ways in this process.
Results
ATRA increases the production of IL-8 in keratin-
ocytes IL-1a is the prominent inducer of IL-8 (Kristensen
et al, 1991; Hoffmann et al, 2002). Moreover, retinoids re-
duce IL-1 induction of IL-8 production in human monocytes
(Gross et al, 1993). Therefore, we initially investigated the
effect of ATRA on IL-1a-induced IL-8 production. Keratin-
ocytes were treated with IL-1a (1 ng per mL) or IL-1a plus
ATRA (106 M), and the IL-8 levels in the culture supernat-
ants were measured after 36 h of incubation. Marked in-
duction of IL-8 was observed in IL-1a-stimulated cells, and
ATRA increased IL-8 production in a synergistic manner
(Fig 1A).
To assess the effect of ATRA on IL-8 production in ker-
atinocytes, we stimulated the keratinocytes with different
concentrations of ATRA. IL-8 mRNA expression was
scarcely detectable by the ribonuclease protection assay
(RPA) in samples that contained the vehicle (dimethyl sulf-
oxide (DMSO)) alone (Fig 1B). After 24 h of treatment with
various doses of ATRA (109–105 M), IL-8 mRNA expres-
sion was increased in a concentration-dependent manner
(Fig 1B). The release of IL-8 into the culture medium was
upregulated in a concentration-dependent manner, and was
consistent with the increase in IL-8 mRNA (Fig 1C).
ATRA increases the expression of the NF-jB family
members in human keratinocytes NF-kB binding is es-
sential for the activation of IL-8 gene transcription (Kunsch
et al, 1994). Several members of the NF-kB family, such as
p50 (NF-kB1), p65 (RelA), c-Rel, and p52 (NF-kB2), have
been shown to bind to the NF-kB motif of the IL-8 promoter
(Kunsch and Rosen, 1993; Stein et al, 1993; Harant et al,
1996a). To characterize the molecular mechanisms under-
lying ATRA-induced IL-8 production in keratinocytes, the
expression of NF-kB family members in ATRA-treated ker-
atinocytes was examined using the RPA. The expression
levels of p65, RelB, p52, and p50 mRNA started to increase
1 h after the addition of ATRA, and persisted for more than
24 h (Fig 2). Although c-Rel was detected faintly 12–48 h
after ATRA treatment, the basal level of expression of c-Rel
mRNA was very low in the RPA.
Figure1
All-trans-retinoic acid (ATRA) simulates the production of inter-
leukin (IL)-8 by human keratinocytes. (A) Subconfluent keratinocyte
cultures were treated with IL-1a (1 ng per mL), ATRA (106 M), or ve-
hicle (dimethyl sulfoxide). After 36 h of incubation, the culture supe-
rnatants were collected and subjected to ELISA for the detection of
IL-8. (B) Keratinocytes were stimulated with ATRA (109–105 M). IL-8
mRNA expression was monitored by RT-PCR after a 24-h incubation.
(C) Keratinocytes were stimulated with ATRA for 36 h, and the level of
secreted IL-8 was measured by ELISA.
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ATRA increases the DNA-binding activity of p65 in hu-
man keratinocytes We also examined the DNA-binding
activities of the NF-kB family members in the nuclear ex-
tracts of ATRA-stimulated keratinocytes. The DNA-binding
activity of p65 increased between 6 and 24 h post-treat-
ment with ATRA (Fig 3A). In addition, ATRA upregulated the
DNA-binding activity of p65 in a concentration-dependent
manner (Fig 3B). In contrast, the DNA-binding activity of p50
was not influenced by ATRA. The DNA-binding activity of
the c-Rel protein was not detected in either ATRA-treated or
untreated keratinocytes (data not shown).
ATRA phosphorylates IjBa in cultured human keratin-
ocytes The inhibitory molecule IkB anchors NF-kB in the
inactive form in the cytosol (Baeuerle and Henkel, 1994). A
crucial step in NF-kB signal transduction involves the dis-
sociation of NF-kB from IkB, which is followed by NF-kB
translocation to the nucleus (Baeuerle and Henkel, 1994).Figure 2
All-trans-retinoic acid (ATRA) increases the expression of nuclear
factor (NF)-jB subunit mRNA. Keratinocytes were exposed to 106 M
ATRA, and total RNA samples were collected at the indicated time
points. The expression levels of the NF-kB subunit mRNAs were ex-
amined using the ribonuclease protection assay.
Figure 3
Nuclear translocation of p65 is increased by all-trans-retinoic acid
(ATRA) treatment. (A) Keratinocytes were stimulated with ATRA (106
M), and the nuclear proteins were extracted at the indicated time
points. An enzyme-linked immunoassay was performed to monitor the
DNA-binding activities of the nuclear factor (NF)-kB subunits in the
nucleus. The relative values for the optical density at 655 nm are nor-
malized to the value of 0 h as 1 U, and are plotted on the graph. (B)
ATRA (109–105 M) was added to subconfluent-conditioned keratin-
ocytes, and the cultures were incubated for 24 h. The DNA-binding
activities of the NF-kB subunits in the nucleus were examined, and the
relative values are normalized to the value for 0 M, which is designated
as 1 U. po0.05; po0.01.
Figure4
All-trans-retinoic acid (ATRA) increases the level of phosphory-
lated IjBa in human keratinocytes. (A) Keratinocytes were stimulated
with ATRA (106 M), and the cellular proteins were extracted at the
indicated time points. Immunoblotting was performed with anti-IkBa
and anti-phospho-specific IkBa antibodies. The relative levels of phos-
phorylated IkBa are estimated using the total level of IkBa protein as
the reference, and these values are normalized against the value at 0
min, which is designated as 1 U. (B) ATRA (109–105 M) was added
and incubated for 24 h. The relative levels of phosphorylated IkBa
protein expression are estimated from the immunoblots. po0.05;
po0.01; po0.001.
1080 DAI ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
The dissociation of NF-kB from IkB requires the phosphor-
ylation of IkB, which results in rapid and ubiquitous degra-
dation of IkB. Thus, the effect of ATRA on the expression
and phosphorylation of IkBa was investigated. ATRA in-
creased the level of phosphorylation of IkBa, although ATRA
had no significant effect on the total level of IkBa protein
(Fig 4A and B). The relative level of expression of phos-
phorylated IkBa to total IkBa was increased significantly, 6 h
post-ATRA treatment, and had increased 1.9-fold at 24 h
(Fig 4A). In our concentration-dependency study, 24 h of
ATRA treatment increased the level of phosphorylated IkBa
1.3-fold at 107 M, 1.9-fold at 106 and 2.2-fold at 105 M,
as compared with vehicle-treated keratinocytes (Fig 4B).
Mutant IjBa abrogates the production of IL-8 by ATRA
in human keratinocytes To determine whether ATRA-in-
duced IL-8 production in keratinocytes was dependent on
NF-kB, we introduced mutated-IkBa (IkBaM) gene using an
adenovirus vector (AxIkBaM), which results in the blockade
of NF-kB signals by unphosphorylated IkBa (Brown et al,
1995; Chen et al, 1995). Keratinocytes were transfected
with AxIkBaM or AxLacZ, and stimulated with ATRA. The
culture supernatants were collected at 12, 24, and 48 h after
the addition of ATRA. The ELISA demonstrated that IkBaM
not only abrogated ATRA-dependent production of IL-8, but
also drastically suppressed the basal production of IL-8
(Fig 5A). IkBaM also suppressed IL-8 mRNA expression in
both ATRA-treated and untreated keratinocytes (Fig 5B).
The increased expression of IkBa protein in IkBaM-
transfected keratinocytes confirms that mutated IkBa per-
sists in the cell and suppresses the NF-kB signal (Fig 5C).
The p38 MAPK inhibitor SB202180 partially suppres-
ses ATRA-induced IL-8 expression in human keratin-
ocytes We investigated whether the p38 pathway was
also involved in ATRA-induced IL-8 gene expression in
keratinocytes. After the addition of ATRA, the phosphor-
ylation of p38 increased, whereas the total level of p38
protein was unchanged (Fig 6A). The phosphorylation of
p38 started at 5 min, peaked at 1 h, and persisted for 24 h
post-treatment with ATRA (Fig 6A). ATRA-dependent p38
phosphorylation was inhibited by SB202180 (Fig 6B). The
cells were treated with 5, 10, or 20 mM of SB202180 for 2 h
before the addition of ATRA, and the keratinocytes were
then incubated for 36 h. ATRA-induced IL-8 production
was inhibited in a concentration-dependent manner by
SB202180 (Fig 6C). Consistent with the decrease in IL-8
production, the levels of ATRA-induced IL-8 mRNA expres-
sion were also decreased in a concentration-dependent
manner by SB202180 (Fig 6D). In this study, SB202180 did
not affect the basal level of IL-8 production (data not
shown).
Discussion
In this study, we demonstrated that ATRA induces IL-8 pro-
duction in cultured normal human keratinocytes. Skin irri-
tation following topical application of retinoic acid at least
partially explained by the local induction of IL-8 production
by epidermal keratinocytes (Kim et al, 2003). IL-1a increas-
es IL-8 production in normal human keratinocytes (Kristen-
sen et al, 1991; Hoffmann et al, 2002), and ATRA increased
IL-8 production with IL-1a synergistically (Fig 1A). This result
is contrary to that of a previous report, in which IL-1-in-
duced IL-8 production by human monocytes was markedly
reduced by retinoids (Gross et al, 1993). Nevertheless, LPS-
induced IL-8 production was increased by ATRA in a same
cell system (Gross et al, 1993). In addition, the synergistic
effects of ATRA and TNF-a and 12-O-tetradecanoylphorbol-
13-acetate on IL-8 gene activation have been reported for
the human melanoma cell line G-361 (Harant et al, 1996b)
and the human acute promyelocytic leukemia cell line (Atk-
ins and Troen, 1995), respectively. Therefore, the effects of
ATRA on IL-8 production vary, according to both cell type
and the co-administered reagent.
Retinoic acid exerts its pleiotropic effects through bind-
ing to two groups of nuclear receptors, the retinoic acid
Figure 5
Blockade of nuclear factor (NF)-jB signaling abrogates the induc-
tion of interleukin (IL)-8 by all-trans-retinoic acid (ATRA). (A) Ker-
atinocytes were transfected with AxIkBaM or AxLacZ at a multiplicity of
infection (MOI)¼2 for 12 h before the addition of ATRA. ATRA (106 M)
or vehicle was then added, and the cultures were incubated for the
indicated time periods. The culture supernatants were collected, and
the levels of IL-8 protein were measured. po0.05; po0.01. (B)
Keratinocytes were transfected with adenovirus vector and stimulated
with ATRA (106 M) or vehicle. The levels of IL-8 and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) mRNA expression 24 h post-
treatment with ATRA were analyzed by RT-PCR. (C) Keratinocytes were
transfected with adenovirus vector and stimulated with ATRA (106 M)
or vehicle. The levels of IkBa protein expression 24 h after ATRA treat-
ment were analyzed by western blotting.
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receptors (RAR-a, -b, -g) and the retinoid X receptors (RXR-
a, -b, -g) (Giguere et al, 1987; Petkovich et al, 1987; Ben-
brook et al, 1988; Brand et al, 1988; Krust et al, 1989). RAR
usually form heterodimers with RXR (Chambon, 1996), and
these dimers are able to bind to specific DNA sequences,
which are known as retinoic acid-responsive elements
(RARE). RAR–RXR complexes act as ligand-inducible tran-
scription factors. The consensus sequence of RARE con-
tains hexanucleotide half-sites that are arranged as inverted
or direct repeats, spaced by various numbers of nt (de The
et al, 1990); however, the IL-8 gene does not contain the
classical ATRA response elements (Baggiolini and Clark-
Lewis, 1992). Therefore, IL-8 induction by ATRA may not
depend on this ‘‘classical pathway’’. In certain cases, re-
tinoic acid has been shown to regulate genes that do not
contain classical RARE motifs (Gudas et al, 1994). These
genes can be regulated by retinoic acid via secondary
events, such as the induction and activation of NF-kB
(Segars et al, 1993). It has been shown that the induction of
major histocompatibility class I genes by retinoic acid in
human embryonal carcinoma NTera2 (NT-2) cells involves
both the activation of RAR–RXR heterodimers and the in-
duction of the NF-kB molecules p50 and p65 (Segars et al,
1993). The binding of NF-kB to the IL-8 promoter is essen-
tial for constitutive activation of IL-8 gene transcription
(Hoffmann et al, 2002), and p65 is one of the major com-
ponents responsible for kB binding to the IL-8 promoter
(Kunsch and Rosen, 1993). ATRA is able to induce IL-8 gene
expression by increasing NF-kB transcriptional activity in
some cells (Harant et al, 1996a; Chang et al, 2000). In airway
epithelium cells, ATRA-enhanced NF-kB binding to the pro-
moter region involves p65 and p50 (Chang et al, 2000). In
the human melanoma cell line G-361, the synergistic effect
of ATRA and TNF-a on IL-8 expression is dependent on their
combined activation of the IL-8 promoter, which requires an
intact NF-kB-binding site (Harant et al, 1996b). In this study,
we show nuclear translocation of p65 and IkB phosphor-
ylation in ATRA-treated keratinocytes. Therefore, ATRA-de-
pendent IL-8 induction probably involves increased levels of
p65 (Segars et al, 1993). Similar effects of ATRA on NF-kB
subunits have been observed in other cell types (Segars
et al, 1993; Feng and Porter, 1999; Farina et al, 2002).
ATRA-mediated increases in the levels of p65 and p50
transcripts are dependent on the ‘‘classical pathway’’.
An alternative mechanism for IL-8 induction via NF-kB
signaling is the phosphorylation of IkBa. Unfortunately, the
molecular mechanism by which ATRA phosphorylates IkBa
is unclear. The introduction of IkBaM completely abolished
Figure 6
The p38 pathway is involved in the induction of interleukin (IL)-8.
(A) Keratinocytes were stimulated with all-trans-retinoic acid (ATRA)
(106 M), and the cellular proteins were extracted at the indicated time
points. Immunoblotting was performed with the anti-p38 and anti-
phospho-specific p38 antibodies. (B) Keratinocytes were treated with
SB202180 (20 mM) for 2 h prior to the addition of ATRA. ATRA (106 M)
or vehicle was then added and the cultures were incubated for 1 h. The
expression levels of p38 and phospho-p38 were examined by western blotting. The intensity of each band was quantified as described in Materials
and Methods, and the graph was made to show the significant effect of p38 inhibitor on ATRA-induced phospho-p38. (C) Keratinocytes were treated
with various concentrations of SB202180 (0–20 mM) for 2 h. ATRA (106 M) or vehicle was then added and the cultures were incubated for 36 h. The
levels of IL-8 in the culture supernatants were determined by ELISA. po0.05; po0.01. (D) Keratinocytes were treated with various concen-
trations of SB202180 (0–20 mM) for 2 h. ATRA (106 M) or vehicle was then added and the cultures were incubated for 18 h. The relative IL-8 mRNA
expression levels were assessed by real-time quantitative RT-PCR.
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IL-8 production and reduced the basal level of IL-8 pro-
duction. These findings suggest that NF-kB activation is
essential in ATRA-induced IL-8 production in normal kera-
tinocytes.
Activation of p38 MAPK was elicited by ATRA in kera-
tinocytes. The finding that the p38 inhibitor SB202180 spe-
cifically decreases ATRA-induced IL-8 production suggests
that the p38 MAPK is also involved in ATRA-induced IL-8
production. A previous report has demonstrated that the
p38 MAPK pathway contributes to cytokine/stress-induced
IL-8 gene expression by stabilizing mRNA through an ARE-
targeted mechanism at the post-transcriptional level (Hoff-
mann et al, 2002). Therefore, ATRA may stabilize IL-8 mRNA
by activating the p38 pathway, thereby enhancing IL-8 pro-
duction in keratinocytes. In summary, ATRA induces IL-8
production in normal human keratinocytes via NF-kB and
the p38 MAPK signal pathways.
Materials and Methods
Cell culture Normal human keratinocytes were cultured in
MCDB153 medium that was supplemented with insulin (5 mg per
mL), hydrocortisone (5  107 M), ethanolamine (0.1 mM), phos-
phoethanolamine (0.1 mM), bovine hypothalamic extract (50 mg per
mL), and Ca2þ (0.03 mM), as described previously (Yamasaki et al,
2003a). The study was conducted according to Declaration of
Helsinki principles. All of the procedures that involved human sub-
jects received prior approval from the Ethical Committee of Ehime
University School of Medicine, and all the subjects provided written
informed consent.
Reagents ATRA was purchased from Sigma Chemical Co (St
Louis, Missouri), and was dissolved in DMSO. Recombinant hu-
man IL-1a was a generous gift from Dainippon Pharmaceutical
Co. Ltd. (Osaka, Japan). The anti-IkBa and anti-phospho-IkBa
antibodies were purchased from Cell Signaling Technology, Inc.
(Beverly, Massachusetts). The p38 MAPK inhibitor SB202180
was purchased from Calbiochem–Novabiochem International Co.
(San Diego, California), dissolved in DMSO at a concentration of
2 mM, and stored at 201C.
Adenovirus construction and infection The cosmid cassette
pAxCAw (Miyake et al, 1996) and the parental virus Ad5-dlX (Mi-
yake et al, 1996) were kind gifts from Dr Izumu Saito (Tokyo Uni-
versity, Japan). The full-length coding region of the IkBaM cDNA
was obtained from the HindIII- and BamHI-digested fragments of
pCMV-IkBaM (BD Biosciences Clontech, Palo Alto, California), and
subcloned into the cosmid cassette pAxCAw. IkBaM encodes the
dominant negative mutant form of IkBa, which is a non-degradable
form of human IkBa, in which serines 32 and 36 are replaced by
alanine residues (S32A/S36A), thereby blocking its phosphorylation
and degradation (Brown et al, 1995; Chen et al, 1995). The NF-kB
signal cannot be activated in cells that over-express IkBaM, re-
gardless of the presence of extracellular stimuli that normally in-
duce the phosphorylation of IkBa and activation of the NF-kB
signal (Brown et al, 1995; Feig et al, 1999). An adenovirus vector
that contains the CAG promoter and IkBaM (AxIkBaM) was gen-
erated using the cosmid cassettes and Ad DNA-TPC (COS-TPC)
method, and virus stocks were prepared using the standard pro-
cedure (Miyake et al, 1996). Concentrated, purified virus stocks
were prepared by CsCl gradient centrifugation, and the virus titer
was estimated in a plaque formation assay.
Subconfluent cultures of normal human keratinocytes were in-
fected with AxIkBaM at a multiplicity of infection (MOI) of 2, and
AxLacZ was used as the control vector. The vectors were cultured
with the cells for 60 min, with a brief period of agitation every 15
min. This was followed by the addition of fresh culture medium,
and re-incubation for 12 h, before treatment with ATRA. The ex-
pression of these genes was confirmed by RT-PCR using specific
probes.
Oligonucleotide probe preparation PCR-amplified human
cDNAs were inserted into the EcoRI and HindIII sites of the pPMG
vector (BD Pharmingen, San Diego, California). The inserted cDNA
corresponded to the following sequences: nt 412–746 of RelA (p65)
(GenBank/EBI accession no. NM021975); nt 709–1013 of RelB
(NM006509); nt 804–1074 of NF-kB2 (p52/p100) (NM002502); nt
877–1122 of NF-kB1 (p50/p105) (NM003998); nt 1758–1982 of c-
Rel (X75042). The pPMG vector (Pharmingen), which incorporates
the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA,
was used as the internal standard.
RPA Total RNA was isolated from cultured human keratinocytes
using Isogen (Nippon Gene, Toyama, Japan). Single-stranded an-
tisense riboprobes were prepared by in vitro transcription of human
cDNA fragments using the RiboQuant In Vitro Transcription Kit
(Pharmingen) in the presence of [a-32P] UTP. The hCK-5 probe
(Pharmingen) for IL-8 detection and an oligonucleotide probe for
NF-kB were used as the templates for the in vitro transcription
reaction. The hybridization products were separated on a gel, and
exposed to photographic film, as described previously (Yamasaki
et al, 2003b). At least three independent studies were performed,
with similar results. One representative experiment is shown in
each figure. The GAPDH bands appear as a doublet, as reported
previously (Dai et al, 2004), which may be because of the fact that
the end of the GAPDH mRNA is highly susceptible to RNase di-
gestion, even though it is double stranded.
RT-PCR Total RNA samples from cultured cells were isolated at
the indicated time points using Isogen (Nippon Gene Co.). RT-PCR
was performed using RT-PCR High Plus (Toyobo, Osaka, Japan),
according to the manufacturer’s instructions. The cDNA was gen-
Figure 7
Schematic representation of a possible mechanism for all-trans-
retinoic acid (ATRA)-dependent induction of interleukin (IL)-8 pro-
duction by keratinocytes. A possible mechanism for ATRA-dependent
induction of IL-8 production by keratinocytes is presented. ATRA
phosphorylates IkBa, which causes nuclear translocation of nuclear
factor (NF)-kB elements, and results in the transactivation of the NF-kB
signal. The increased levels of p65 and p50 induced by ATRA may also
contribute to activation of the NF-kB signal. Activation of the p38 mi-
togen-activated protein kinase (MAPK) pathway may play a role in IL-8
mRNA stabilization and IL-8 production.
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erated from reverse transcription of total RNA for 30 min at 601C,
and then heated to 941C for 2 min. The PCR cycle consisted of
1 min at 941C for denaturation, and 1.5 min at 601C for annealing
and primer extension. The IL-8 sequences were amplified for 34
cycles, and the GAPDH sequences for 22 cycles. The following
primer pairs were used: human IL-8, 50-CTTCTCTGCAGCA-
CATCC-30 and 50-AAGACCTCTCAAGGCTTTG-30; and GAPDH,
50-ACCACAGTCCATGCCATCAC-30 and 50-TCCACCACCCTGTT-
GCTGTA-30. The PCR products were visualized on 2% agarose
gels that contained ethidium bromide. The PCR products were
sequenced, to confirm the accuracy of amplification.
Real-time quantitative PCR Total RNA samples from cultured
cells were isolated using Isogen (Nippon Gene Co.). Real-time RT-
PCR was performed in the ABI PRISM 7700 sequence detector (PE
Applied Biosystems, Branchburg, New Jersey). The Pre-Devel-
oped TaqMan assay reagents (set of primers and probe) for human
IL-8 (Accession Numbers: NM_000584) and for human GAPDH
endogenous control (Accession Numbers: NM_002046) were pur-
chased from Applied Biosystems (Foster City, California). The RNA
analysis was undertaken using the TaqMan One-Step RT-PCR
Master Mix reagents kit (PE Applied Biosystems) and 500 ng of
total RNA. Thermal cycling was initiated at 481C for 30 min for
reverse transcription reaction, followed by a first denaturation step
at 951C for 10 min, and then 40 cycles PCR at 951C for 15 s and at
601C for 1 min according to the manufacturer’s instructions using
2  AmpliTaq Gold DNA Polymerase mix (25 mL), 40  RT enzyme
mix (1.25 mL), 20  Pre-Developed TaqMan assay reagent (2.5 mL).
All one-step RT-PCR reactions were performed in 50 mL reaction
volumes, and carried out in a 96-well plate. This experiment used
two dye layers to detect the presence of target and control se-
quences. The 6-FAM dye layer yielded the results for quantification
of IL-8 mRNA, and the VIC dye layer yielded the results for quan-
tification of GAPDH. Quantification of gene expression was per-
formed using the comparative cycle threshold (CT) method
(Sequence Detector User Bulletin 2; Applied Biosystems) and
reported as the fold difference relative to GAPDH gene. To calcu-
late the fold change (increase or decrease), the CT of the house-
keeping gene (GAPDH) was subtracted from the CT of the target
gene (IL-8) to yield the DCT. Change in expression of the normal-
ized target gene as a result of an experimental manipulation was
expressed as 2DDCT where DDCT¼DCT sample—DCT control as
described previously (Babu and Nutman, 2003). In this study, each
assay was performed in triplicate, and the fold change of each
sample was normalized against that of the vehicle as 1 U.
ELISA Culture supernatants were collected at the indicated time
points after treatment, and stored at 701C until used for ELISA.
The IL-8 ELISA kit was purchased from R&D Systems (Minneapo-
lis, Minnesota), and used according to the manufacturer’s instruc-
tions. The optical density at 450 nm was measured with an Immuno
Mini NJ-2300 microplate reader (Nalge Nunc International K.K.,
Tokyo, Japan). All of the assays were performed at least three
times.
Western blot analysis The cells were harvested by scraping into
extraction buffer that contained 150 mM NaCl, 1% Nonidet P-40,
0.5% deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 50 mM
Tris-HCl (pH 7.4), and protease inhibitors. Equal amounts of protein
were separated by SDS-polyacrylamide gel electrophoresis, and
transferred to polyvinylidene difluoride membranes. The analysis
was performed using the Vistra ECF Kit (Amersham Biosciences
K.K., Tokyo, Japan) and the FluoroImager (Molecular Dynamics
Inc., Sunnyvale, California), as described previously (Yamasaki
et al, 2003b). At least three independent studies were performed,
with similar results. One representative experiment is shown in each
of the figures. The intensity of each band was quantified using
ImageQuant (Molecular Dynamics Inc.), with reference to the control
signal, which was assigned the value of 1 U. Reproducibility was
confirmed by performing three independent experiments.
Nuclear protein preparation and detection of transcription
factor activity Nuclear proteins were prepared according to the
instructions provided in the TransFactor Extraction Kit (BD Bio-
sciences Clontech, Palo Alto, California). Briefly, cells were
harvested in lysis buffer (10 mM HEPES (pH 7.9), 10 mM KCl,
1.5 mM MgCl2, 1 mM DTT) that contained protease inhibitors. Nu-
clear pellets were collected by centrifugation, and resuspended in
extraction buffer (20 mM HEPES (pH 7.9), 420 mM NaCl, 1.5 mM
MgCl2, 0.2 mM EDTA, 25% glycerol, 1 mM DTT) that contained
protease inhibitors. Finally, the protein concentrations of the nu-
clear extracts were determined, and the samples were stored at
701C until used.
DNA-binding activities of the NF-kB family members were de-
termined using the BD Mercury Transfactor Kits (BD Biosciences
Clontech), according to the manufacturer’s instructions. The rela-
tive optical density values at 655 nm were normalized to the control
values (at 0 h or for 0 M), which were designated as 1 U, and
plotted on a graph. All of the assays were performed on at least
three separate occasions.
Statistical analyses The data were collected from at least three
independent experiments. Quantitative data are expressed as the
mean  SE. Statistical significance was determined by the paired
Student’s t test. Differences were considered to be statistically
significant for po0.05. The levels of statistical significance are
indicated, as follows, in the figures: po0.05; po0.01; and
po0.001.
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